Status:

COMPLETED

Intestinal Flora Sequencing for Nasopharyngeal Carcinoma

Lead Sponsor:

The Third Xiangya Hospital of Central South University

Conditions:

Nasopharyngeal Carcinoma

Eligibility:

All Genders

18-75 years

Brief Summary

This study investigated the correlation between the changes in the intestinal flora and NPC by an examination of the intestinal flora and multiple clinical indicators of the blood of 8 carefully scree...

Detailed Description

Nasopharyngeal carcinoma (NPC) is a malignant nasopharyngeal disease with a complicated etiology that occurs mostly in southern China. Intestinal flora imbalance is believed to be associated with a va...

Eligibility Criteria

Inclusion

  • NPC patients with a first degree family history of NPC
  • NPC patients without any kind of tumor family history

Exclusion

  • Informed refusal.
  • Lack of necessary tests and patient test information is not detailed

Key Trial Info

Start Date :

August 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 30 2019

Estimated Enrollment :

568 Patients enrolled

Trial Details

Trial ID

NCT04094545

Start Date

August 1 2018

End Date

May 30 2019

Last Update

September 19 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the Third Xiangya Hospital of Central South University

Changsha, Hunan, China, 410006